RooLife Group Ltd (ASX: RLG) Share Price and News
Price
$0.005
Movement
0.0005 (+11.11%)
as at 3 Jun - Closed (20 mins delayed)
52 Week Range
$0.0025 - $0.007
1 Year Return
+38.89%
RooLife Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
$0.005
Day Change
0.0005 (+11.11%)
52 Week Range
$0.0025 - $0.007
Yesterday's Close
$0.0045
Today's Open
$0.0045
Days Range
$0.0045 - $0.005
Volume
4,299,205
Avg. Volume (1 month)
750,730
Turnover
$21,075
as at 3 Jun - Closed
RooLife Group Ltd (ASX: RLG)
Latest News
No posts found.
RLG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|
About RooLife Group Ltd
RooLife Group Ltd is engaged in the provision of fully integrated digital marketing and customer acquisition services driving online sales of products and services. Powered by its hyper-personalization and profiling Artificial IntelligenceSystem, the company provides personalized real-time, targeted marketing, with a key focus on driving sales via its e-commerce marketplaces, enabling businesses to sell directly to consumers. The company focuses on markets and sells food, beverage and health and wellness products in the markets it operates in and also sells its own health and food brand. Geographically, the company generates maximum revenue from China.
RLG Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
30 May 2025 | $0.01 | $0.00 | 0.00% | 7,657,763 | $0.01 | $0.01 | $0.00 |
28 May 2025 | $0.00 | $0.00 | 0.00% | 25,000 | $0.00 | $0.00 | $0.00 |
27 May 2025 | $0.00 | $0.00 | 0.00% | 179,246 | $0.00 | $0.00 | $0.00 |
23 May 2025 | $0.00 | $0.00 | 0.00% | 200,000 | $0.00 | $0.00 | $0.00 |
22 May 2025 | $0.00 | $0.00 | 0.00% | 1,099,104 | $0.00 | $0.00 | $0.00 |
19 May 2025 | $0.00 | $0.00 | 0.00% | 205,000 | $0.00 | $0.00 | $0.00 |
16 May 2025 | $0.00 | $0.00 | 0.00% | 100,000 | $0.00 | $0.00 | $0.00 |
14 May 2025 | $0.00 | $0.00 | 0.00% | 38,174 | $0.00 | $0.00 | $0.00 |
12 May 2025 | $0.00 | $0.00 | 0.00% | 511,000 | $0.01 | $0.01 | $0.00 |
09 May 2025 | $0.01 | $0.00 | 0.00% | 802,222 | $0.00 | $0.01 | $0.00 |
08 May 2025 | $0.00 | $0.00 | 0.00% | 380,000 | $0.00 | $0.00 | $0.00 |
07 May 2025 | $0.00 | $0.00 | 0.00% | 2,174,755 | $0.00 | $0.00 | $0.00 |
05 May 2025 | $0.01 | $0.00 | 0.00% | 979,559 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
29 Nov 2024 | Bryan Carr | Expiry | 8,750,000 | $43,750 |
As advised by the company. Expiry
|
29 Nov 2024 | Grant Pestell | Expiry | 2,333,334 | $11,666 |
As advised by the company. Expiry
|
29 Nov 2024 | Ye (Shenny) Ruan | Expiry | 1,166,667 | $5,833 |
As advised by the company. Expiry
|
26 Sep 2024 | Ye (Shenny) Ruan | Issued | 7,500,000 | $30,000 |
Rights issue.
|
26 Sep 2024 | Ye (Shenny) Ruan | Issued | 3,750,000 | $11,250 |
Rights issue.
|
26 Sep 2024 | Terence Leung | Issued | 50,000,000 | $200,000 |
Rights issue.
|
26 Sep 2024 | Terence Leung | Issued | 25,000,000 | $75,000 |
Rights issue.
|
26 Sep 2024 | Grant Pestell | Issued | 2,500,000 | $7,500 |
Rights issue.
|
26 Sep 2024 | Grant Pestell | Issued | 5,000,000 | $20,000 |
Rights issue. As per announcement on 02-10-2024
|
26 Sep 2024 | Bryan Carr | Issued | 6,875,000 | $20,625 |
Rights issue.
|
26 Sep 2024 | Bryan Carr | Issued | 13,750,000 | $55,000 |
Rights issue.
|
19 Aug 2024 | Grant Pestell | Expiry | 2,333,333 | $10,499 |
As advised by the company. 2,333,334 Performance Rights, expired
|
19 Aug 2024 | Ye (Shenny) Ruan | Expiry | 1,666,667 | $7,500 |
As advised by the company. 1,166,667 Performance Rights, expired
|
19 Aug 2024 | Bryan Carr | Expiry | 8,750,000 | $39,375 |
As advised by the company. 8,750,000 Performance Rights, expired
|
14 Aug 2024 | Terence Leung | Expiry | 8,000,000 | $40,000 |
As advised by the company. Expiry of convertible debt securities on repayment
of convertible debt. |
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr Bryan Carr | Chief Executive OfficerManaging Director | Dec 2018 |
Mr Carr is an experienced ASX public company Managing Director and Chief Executive Officer with operating experience in Australia and China. He has over 20 years of experience working in technology companies in the private and public company environment where he has developed business development skills and corporate governance, finance, capital markets and risk management expertise. In addition to his experience in the Australian corporate environment, Mr Carr has understanding of Asia-based business operations, including 10 years based in China during which time he developed an understanding of China and Hong Kong's commercial, corporate and regulatory operating requirements.
|
Mr Grant Anthony Pestell | Non-Executive ChairmanNon-Executive Director | Jul 2016 |
Mr Pestell is founding director of Murcia Pestell Hillard solicitors, who act for the Company. He has over 20 years of experience in commercial litigation, corporate and commercial law with experience advising listed and private companies in the Information & Technology, Energy Resources and Mining Resources Industries; and Managing Director of Murcia Pestell Hillard since 2000. Other current listed directorships include Non-Executive Director of COSOL Limited from August 2019.
|
Mr Reece OConnel | Non-Executive Director | Feb 2025 |
Mr OConnell is a fund manager who brings capital markets and investor relations skills, experience and network connections. He specialises in recognising and funding early-stage companies. Reece is currently Fund Manager of Summit Biotech Fund (formerly Merchant Biotech Fund).
|
Mr Jeremy Baldock | Non-Executive Director | Feb 2025 |
Mr Baldock has 25 years experience in the stockbroking industry in Australia, including 20 years at Bell Potter Securities. Mr Baldock has provided corporate and execution services for a range of corporate and private high net worth clients. Jeremy is currently a senior advisor at Alto Capital, a boutique advisory firm that specialises in ASX mid to small market capitalisation stocks and has assisted many companies with raisings and placements.
|
Mrs Jyotika Gondariya | Chief Financial OfficerCompany Secretary | Mar 2022 |
-
|
Jyotika Gondariya | Chief Financial OfficerCompany Secretary |
-
|
|
Warren Barry | Head of Sales |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Mega Holdings Pty Ltd | 80,660,954 | 10.16% |
China Hong Kong Yuanzhuang Sauce Wine Supply Chain Ltd | 58,823,529 | 7.41% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 57,152,456 | 7.20% |
Mr Jay Shah | 32,338,332 | 4.07% |
Mr Lincoln Ho | 27,500,000 | 3.46% |
Mr Warren Leslie Barry and Mrs Sonia Anne Barry <Barry Family Superfund A/C> | 22,158,388 | 2.79% |
BNP Paribas Noms Pty Ltd | 22,103,041 | 2.78% |
Hedland Bus Lines Pty Ltd | 13,832,523 | 1.74% |
Mr Bryan Edward Carr <Shabaz Family A/C> | 12,250,000 | 1.54% |
Fujian Jushi Supply Chain Management Co Ltd | 11,764,706 | 1.48% |
Mr Mark August Nickel | 11,000,000 | 1.39% |
Mr Franco Antonello | 10,100,000 | 1.27% |
Morckstow Pty Ltd | 10,000,000 | 1.26% |
Mr Bradley Saxby | 9,087,323 | 1.14% |
Pelliccione Sf Pty Ltd <Pelliccione S/F A/C> | 8,963,782 | 1.13% |
Mr Peter Graeme Faull | 8,891,276 | 1.12% |
Next Generation Fisheries Pty Ltd | 8,245,614 | 1.04% |
Citicorp Nominees Pty Limited | 7,939,704 | 1.00% |
Barry Consulting Pty Ltd <Barry Family A/C> | 7,830,663 | 0.99% |
Mr Duminda Sudath Amarakoon and Mrs Geraldine Geethani Roshini Amarakoon <Duro Superfund A/C> | 7,450,000 | 0.94% |